Jubilant Life Sciences owned subsidiary, Jubilant Biosys, has announced on 20th May that it has recently added advanced Pioneer FE system to their platform of drug recovery system and it is available for customers. The added advanced Pioneer FE system is the idea of Forte Bio which is biologics business unit of molecular devices.
The Pioneer FE system outlines the next generation SPR instrumentation for label-free characterization of biomolecules. It is capable of checking high affinity and covalent binding events. Besides, it also uses a rare OneStep gradient injection technology to carry fragment screening of 768 fragments in 24 hours.
Greg Milosevich, President of Forte Bio’s Molecular Devices, said, “We are pleased to have Jubilant adopt the Pioneer platform and look forward to supporting them and their customers’ goals in fast-tracking small molecule drug discovery programs.”
Jubilant Biosys has become the first Indian biochemical company which has placed the Pioneer system in its business. This Contract Research Organization often looks for investing in new technologies to support its innovative customers. Marcel Velterop is the president of Jubilant Biosys. He said that the placement of the Pioneer SPR system in the business would exceptionally develop and speed up their small-molecule system.
Jubilant Biosys is a global pharmaceutical and life sciences company that has a presence in Bengaluru and Noida in India. It has shown expertise in therapeutic areas, including functional and integrated discovery services. The involvement of the Pioneer System would help scientist to improve productivity and effectiveness for discovering new therapeutics.